- E-mailUna.Solvik@uib.no
- Phone+47 55 58 67 27
- Visitor AddressHaraldsplass diakonale sykehus, NoklusSMU-bygget, Ulriksdal 85009 Bergen
- Postal AddressPostboks 78045020 Bergen
Affiliated with the research groups SMIL og Arbeid, Helse og Kjønn
My main research interests:
- Laboratorymedisin
- Diabetes
- Coagulation - INR
- Self control anticoagulant treatment
- Analytical quality control
- Women's health
Associated with Section for Health Sciences and Teaching group leader for Health and Society
Associated with master in Health and Society and Masters in Health Science.
Associated with Program selection for master's in health sciences, IGS, UiB
Emneansvarlig i emnene Forskningsmetode (HELSAM303) og Kvantitative forskningsmetodar og tradisjonar (HELSAM305)
Koordinator for Masterprogram i helsevitenskap, studieretning for radiografer og bioingeniører
Academic article
- (2021). Type 2-diabetes i fastlegepraksis – en fokusgruppestudie. Tidsskrift for Den norske legeforening. 1-9.
- (2020). Pharmacists’ experience of a diabetes risk-assessment service and analytical quality control in community pharmacies – A focus-group study. Research in Social and Administrative Pharmacy. 1259-1266.
- (2020). Performance and user-friendliness of the rapid antigen detection tests QuickVue Dipstick Strep A test and DIAQUICK Strep A Blue Dipstick for pharyngotonsillitis caused by Streptococcus pyogenes in primary health care. European Journal of Clinical Microbiology and Infectious Diseases. 549-558.
- (2019). Quality of warfarin therapy and quality of life are improved by self-management for two years. Thrombosis and Haemostasis. 1632-1641.
- (2019). Commutability of a whole-blood external quality assessment material for point-of-care C-reactive protein, glucose, and hemoglobin testing. Clinical Chemistry. 791-797.
- (2018). The EuBIVAS: Within- and between-subject biological variation data for electrolytes, lipids, urea, uric acid, total protein, total bilirubin, direct bilirubin, and glucose. Clinical Chemistry. 1380-1393.
- (2018). Risk assessment and HbA1c measurement in Norwegian community pharmacies to identify people with undiagnosed type 2 diabetes ? A feasibility study. PLOS ONE. 1-13.
- (2018). Quality control of Norwegian pharmacy HbA1c testing: a modest beginning. Journal of Diabetes Science and Technology. 753-761.
- (2017). The EuBIVAS project: within- and between-subject biological variation data for serum creatinine using enzymatic and alkaline picrate methods and implications for monitoring. Clinical Chemistry. 1527-1536.
- (2017). Intensive educational efforts combined with external quality assessment improve the preanalytical phase in general practitioner offices and nursing homes. Clinical Chemistry and Laboratory Medicine. 1857-1864.
- (2017). Biological variation estimates obtained from 91 healthy study participants for 9 enzymes in serum. Clinical Chemistry. 1141-1150.
- (2016). The potential for deprescribing in care home residents with Type 2 diabetes. International Journal of Clinical Pharmacy. 977-984.
- (2016). Sample collections from healthy volunteers for biological variation estimates' update: A new project undertaken by the Working Group on Biological Variation established by the European Federation of Clinical Chemistry and Laboratory Medicine. Clinical Chemistry and Laboratory Medicine. 1599-1608.
- (2016). 'I try not to bother the residents too much' - the use of capillary blood glucose measurements in nursing homes. BMC Nursing.
- (2015). Egenkontroll av warfarinbehandling. Tidsskrift for Den norske legeforening. 849-853.
- (2014). The influence of coagulation factors on the in-treatment biological variation of international normalized ratio for patients on warfarin. Scandinavian Journal of Clinical and Laboratory Investigation. 470-476.
- (2014). Nursing home patients with diabetes: Prevalence, drug treatment and glycemic control. Diabetes Research and Clinical Practice. 102-109.
- (2013). External quality assessment of point-of-care methods: model for combined assessment of method bias and single-participant performance by the use of native patient samples and noncommutable control materials. Clinical Chemistry. 363-371.
- (2013). Diagnosing Diabetes Mellitus: Performance of Hemoglobin A(1c) Point-of-Care Instruments in General Practice Offices. Clinical Chemistry. 1790-1801.
- (2012). Effect of coagulation factors on discrepancies in International Normalized Ratio results between instruments. Clinical Chemistry and Laboratory Medicine. 1611-1620.
- (2010). Discrepancies in International Normalized Ratio Results between Instruments: A Model to Split the Variation into Subcomponents. Clinical Chemistry. 1618-1626.
- (2009). Internal quality control of prothrombin time in primary care: comparing the use of patient split samples with lyophilised control materials. Thrombosis and Haemostasis. 593-600.
- (2009). Internal quality control of prothrombin time in primary care: comparing the use of patient split samples with lyophilised control materials. Thrombosis and Haemostasis. 593-600.
- (2006). External quality assessment of prothrombin time: the split-sample model compared with external quality assessment with commercial control material. Scandinavian Journal of Clinical and Laboratory Investigation. 337-350.
- (2006). External quality assessment of prothrombin time: The split-sample model compared with external quality assessment with commercial control material. Scandinavian Journal of Clinical and Laboratory Investigation. 337-349.
- (1994). The effect of serum amyloid protein A fragment-SAA25-76 on blood platelet aggregation. Thrombosis Research. 299-305.
- (1994). Modulation of thrombotic responses in moderately stenosed arteries by cigarette smoking and aspirin ingestion. Arteriosclerosis and thrombosis. 617-621.
Reader opinion piece
- (2007). Response to Kitchen et al.'s external quality assessment of prothrombin time: The split-sample model compared to external quality assessment with commercial control material. Scandinavian Journal of Clinical and Laboratory Investigation. 676-677.
Masters thesis
- (2013). Rolleutvidelse ved noen bildediagnostiske avdelinger i Norge.
- (2013). PGMI klassifisering av mammografibilder ved interne og eksterne mamma-radiografer.
- (2013). Er laboratorierutiner og laboratoriekvalitet ved norske sykehjem endret? Har opplæring og oppfølging initiert av Noklus som del av Omsorgsplan 2015 nyttet?
- (2012). Sammenligning av nukleinsyre isoleringsteknikker i forbindelse med etablering av qPCR påvisningsmetode for Borrelia infeksjon.
- (2011). Videreutdanning i Ultralyd for radiografer I hvilken grad er læringsmålene nådd? En kontrollert prospektiv sammenlignende studie 6 mnd etter endt utdanning.
- (2011). Trygg antikoagulasjonsbehandling: Pasienter i Norge kan drive egenkontroll av warfarinbehandling.
- (2011). Tredimensjonale ultralyd volummålinger IN VITRO validering av metode til oppfølging av abdominale aortaaneurismer.
- (2011). Strålebehandling til kvinner med brystkreft Endring av venstre ventrikkels ejeksjonsfraksjon (LVEF) gjennom et behandlingsforløp med strålebehandling, målt med den nukleærmedisinske metoden planar MUGA- scan.
- (2011). Bildeveiledet stråleterapiVil bruk av konvensjonell stimulator bidra til å minimere systematiske innstillingsavvik, og dermed øke innstillingspresisjonen, sammenlignet med bildeveiledet innstilling på behandlingsapparat?
- (2010). Utfordringer ved digital bildeteknologi; en kvalitativ studie av radiografers rolle og deres oppfatning av bildekvalitet ved arbeid med digitale røntgenbilder.
- (2010). Hvordan lav og høy temperatur påvirker måling av blodsukker med apparater i bruk av personer med diabetes.
- (2010). Feltstyrke ved Magnetisk Resonansskanning af håndled og fingrenes led hos pasienter med leddegigt.
- (2010). Deteksjon av tidlige veggforandringer i halsarterier hos barn og unge med type-1 diabetes.
- (2010). Betydning av pasientleie for tynntarmsdose ved strålebehandling av pasienter med rectumcancer.
- (2010). Betydning av behandlingsleie for reproduserbarhet ved strålebehandling av rectumcancer.
- (2009). Strålebehandling av pasienter med brystkreft og bruk av intensitetsmodulert radioterapi (IMRT).
- (2009). Processerings optimering med Canons software -et fantom projekt om dosis besparelse ved anvendelse af Canons nye DR Spectra software på børnefemur undersøgelser.
- (2007). Analyse av protrombintid i primærhelsetjenesten - vurdering av analysekvalitet og en evaluering av to kontrollsystem for analytisk kvalitetskontroll ved hjelp av datasimuleringer.
Letter to the editor
- (2018). Hemolysis interference studies: Freeze method should be used in the preparation of hemolyzed samples. Clinical Chemistry and Laboratory Medicine. 1-3.
- (2017). Effect of dabigatran treatment at therapeutic levels on point-of-care international normalized ratio (INR). Clinical Chemistry and Laboratory Medicine. e143-e145.
- (2015). Performance of 10 systems for self-monitoring of blood glucose by trained healthcare professionals and in the hands of the users. Clinical Chemistry. 772-774.
Doctoral dissertation
- (2019). Diabetes in care homes. Special emphasis on medicines and blood glucose measurements.
Abstract
- (2005). External quality assessments of whole blood prothrombin time: Comparison of two methods. Clinica Chimica Acta.
Poster
- (2016). ‘It’s a jungle out there’ - A focus group study about being diagnosed with type 2 diabetes.
- (2016). A feasibility study for risk assessment ofType 2 Diabetes (T2D) in pharmacies.
More information in national current research information system (CRIStin)
Fields of competence